Top

Published in:

18-08-2021 | Cardiomyopathy | Case Presentation Corner

Stress cardiomyopathy as a cause of reverse redistribution with Tc-99m tetrofosmin regadenoson-rest myocardial perfusion imaging

Authors: Luke Joseph, MD, Stephen Clarkson, MD, Brittain Heindl, MD, Ami E. Iskandrian, MD, MASNC, Fadi G. Hage, MD, FAHA, FACC, MASNC

Published in: Journal of Nuclear Cardiology | Issue 1/2023

Excerpt

A 79-year-old woman with hypertension, hyperlipidemia, prior breast cancer, alcohol dependence, and a 50 pack year smoking history presented to the emergency department at the University of Alabama at Birmingham (UAB) medical center with two days of dyspnea, cough, and chest pain. Her cough developed first, and she attributed it to an upper respiratory infection. She subsequently developed exertional dyspnea and sharp central chest pain and presented to the emergency department. …

Available only for authorised users

Oruc V, Farag AA, Hage FG. What is this image? 2021: Image 5 result: Progression of myocardial ischemia to scar on serial (99m)Tc-sestamibi myocardial perfusion imaging. J Nucl Cardiol 2021;28:399-403. (In eng). https://doi.org/10.1007/s12350-021-02580-3CrossRefPubMed

Soufer R, Dey HM, Lawson AJ, Wackers FJ, Zaret BL. Relationship between reverse redistribution on planar thallium scintigraphy and regional myocardial viability: A correlative PET study. J Nucl Med 1995;36:180-87. (In eng)PubMed

Weiss AT, Maddahi J, Lew AS et al. Reverse redistribution of thallium-201: A sign of nontransmural myocardial infarction with patency of the infarct-related coronary artery. J Am Coll Cardiol 1986;7:61-67. (In eng). https://doi.org/10.1016/s0735-1097(86)80260-1CrossRefPubMed

Amin HZ, Amin LZ, Pradipta A. Takotsubo cardiomyopathy: A brief review. J Med Life 2020;13:3-7. (In eng). https://doi.org/10.25122/jml-2018-0067CrossRefPubMedPubMedCentral

Vizzardi E, D’Aloia A, Zanini G et al. Tako-tsubo-like left ventricular dysfunction: Transient left ventricular apical ballooning syndrome. Int J Clin Pract 2010;64:67-74. (In eng). https://doi.org/10.1111/j.1742-1241.2008.01833.xCrossRefPubMed

Manabe O, Naya M, Oyama-Manabe N, Koyanagawa K, Tamaki N. The role of multimodality imaging in Takotsubo cardiomyopathy. J Nucl Cardiol 2019;26:1602-16. (In eng). https://doi.org/10.1007/s12350-018-1312-xCrossRefPubMed

Sharkey SW, Windenburg DC, Lesser JR et al. Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol 2010;55:333-41. (In eng). https://doi.org/10.1016/j.jacc.2009.08.057CrossRefPubMed

Kobylecka M, Budnik M, Kochanowski J et al. Takotsubo cardiomyopathy: FDG myocardial uptake pattern in fasting patients. Comparison of PET/CT, SPECT, and ECHO results. J Nucl Cardiol 2018;25:1260-70. (In eng). https://doi.org/10.1007/s12350-016-0775-xCrossRefPubMed

Wittstein IS, Thiemann DR, Lima JA et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005;352:539-48.(In eng). https://doi.org/10.1056/NEJMoa043046CrossRefPubMed

10.

Pelliccia F, Kaski JC, Crea F, Camici PG. Pathophysiology of Takotsubo syndrome. Circulation 2017;135:2426-41. (In eng). https://doi.org/10.1161/circulationaha.116.027121CrossRefPubMed

11.

Templin C, Ghadri JR, Diekmann J et al. Clinical features and outcomes of Takotsubo (Stress) cardiomyopathy. N Engl J Med 2015;373:929-38. (In eng). https://doi.org/10.1056/NEJMoa1406761CrossRefPubMed

12.

Koester C, Warner C, Hafiz AM, Martin R. A case of bronchospasm-induced Takotsubo cardiomyopathy during adenosine stress testing. J Nucl Cardiol 2020;27:2421-25. (In eng). https://doi.org/10.1007/s12350-019-01996-2CrossRefPubMed

13.

Morgan W, Hage F. Stress cardiomyopathy associated with vasodilator stress testing. J Nucl Cardiol 2020;27:2426-28. (In eng). https://doi.org/10.1007/s12350-020-02064-wCrossRefPubMed

14.

Rajwani A, Adam Z, Hall JA. Bronchogenic stress cardiomyopathy: A case series. Cardiology 2015;130:106-11. (In eng). https://doi.org/10.1159/000369296CrossRefPubMed

15.

Wittstein IS. Stress cardiomyopathy: A syndrome of catecholamine-mediated myocardial stunning? Cell Mol Neurobiol 2012;32:847-57. (In eng). https://doi.org/10.1007/s10571-012-9804-8CrossRefPubMed

16.

Cohen RA, Shepherd JT, Vanhoutte PM. Prejunctional and postjunctional actions of endogenous norepinephrine at the sympathetic neuroeffector junction in canine coronary arteries. Circ Res 1983;52:16-25. (In eng). https://doi.org/10.1161/01.res.52.1.16CrossRefPubMed

17.

Alexanderson E, Cruz P, Talayero JA, Damas F, Zerón J, Meave A. Transient perfusion and motion abnormalities in Takotsubo cardiomyopathy. J Nucl Cardiol 2007;14:129-33. (In eng). https://doi.org/10.1016/j.nuclcard.2006.11.005CrossRefPubMed

18.

Verberne HJ, van der Heijden DJ, van Eck-Smit BL, Somsen GA. Persisting myocardial sympathetic dysfunction in Takotsubo cardiomyopathy. J Nucl Cardiol 2009;16:321-24. (In eng). https://doi.org/10.1007/s12350-008-9017-1CrossRefPubMedPubMedCentral

19.

Morel O, Sauer F, Imperiale A et al. Importance of inflammation and neurohumoral activation in Takotsubo cardiomyopathy. J Card Fail 2009;15:206-13. (In eng). https://doi.org/10.1016/j.cardfail.2008.10.031CrossRefPubMed

20.

Hadase M, Kawasaki T, Asada S, Kamitani T, Kawasaki S, Sugihara H. Reverse redistribution of Tc-99m tetrofosmin in a patient with “Takotsubo” cardiomyopathy. Clin Nucl Med 2003;28:757-59. (In eng). https://doi.org/10.1097/01.rlu.0000082665.77650.e2CrossRefPubMed

21.

Ghadri JR, Wittstein IS, Prasad A et al. International expert consensus document on takotsubo syndrome (Part II): Diagnostic workup, outcome, and management. Eur Heart J 2018;39:2047-62. (In eng). https://doi.org/10.1093/eurheartj/ehy077CrossRefPubMedPubMedCentral

22.

Ueyama T, Kasamatsu K, Hano T, Yamamoto K, Tsuruo Y, Nishio I. Emotional stress induces transient left ventricular hypocontraction in the rat via activation of cardiac adrenoceptors: A possible animal model of “tako-tsubo” cardiomyopathy. Circ J 2002;66:712-13. (In eng). https://doi.org/10.1253/circj.66.712CrossRefPubMed

23.

Marfella R, Barbieri M, Sardu C et al. Effects of α-lipoic acid therapy on sympathetic heart innervation in patients with previous experience of transient Takotsubo cardiomyopathy. J Cardiol 2016;67:153-61. (In eng). https://doi.org/10.1016/j.jjcc.2015.07.012CrossRefPubMed

24.

Akashi YJ. Long-term prognosis in patients with Takotsubo syndrome. Eur J Heart Fail 2019;21:790-91. (In eng). https://doi.org/10.1002/ejhf.1417CrossRefPubMed

25.

Sharkey SW, Maron BJ. Survival after Takotsubo, revisited. J Am Coll Cardiol 2018;72:883-84. (In eng). https://doi.org/10.1016/j.jacc.2018.06.022CrossRefPubMed

26.

Citro R, Radano I, Parodi G et al. Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction. Eur J Heart Fail 2019;21:781-89. (In eng). https://doi.org/10.1002/ejhf.1373CrossRefPubMed

Title: Stress cardiomyopathy as a cause of reverse redistribution with Tc-99m tetrofosmin regadenoson-rest myocardial perfusion imaging
Authors: Luke Joseph, MD
Stephen Clarkson, MD
Brittain Heindl, MD
Ami E. Iskandrian, MD, MASNC
Fadi G. Hage, MD, FAHA, FACC, MASNC
Publication date: 18-08-2021
Publisher: Springer International Publishing
Keywords: Cardiomyopathy
Acute Coronary Syndrome
Published in: Journal of Nuclear Cardiology / Issue 1/2023
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-021-02754-z

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Stress cardiomyopathy as a cause of reverse redistribution with Tc-99m tetrofosmin regadenoson-rest myocardial perfusion imaging

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

18F-FDG PET/CT for the diagnosis of aortic inflammation in COVID-19

Does [99mTc]-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) soft tissue uptake allow the identification of patients with the diagnosis of cardiac transthyretin-related (ATTR) amyloidosis with higher risk for polyneuropathy?

Time-related aortic inflammatory response, as assessed with 18F-FDG PET/CT, in patients hospitalized with severely or critical COVID-19: the COVAIR study

The “power of zero” CAC validated for absence of ischemia on PET?

The chest pain guidelines revisited: cherry picking from the frequentist tree

Deep learning prediction of quantitative coronary angiography values using myocardial perfusion images with a CZT camera

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page